Production of tetra-methylpyrazine using engineered Corynebacterium glutamicum. by Eng, Thomas et al.
Lawrence Berkeley National Laboratory
Recent Work
Title
Production of tetra-methylpyrazine using engineered Corynebacterium glutamicum.
Permalink
https://escholarship.org/uc/item/6mz578cp
Journal
Metabolic Engineering Communications, 10
ISSN
2214-0301
Authors
Eng, Thomas
Sasaki, Yusuke
Herbert, Robin A
et al.
Publication Date
2020-06-01
DOI
10.1016/j.mec.2019.e00115
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Metabolic Engineering Communications 10 (2020) e00115Contents lists available at ScienceDirect
Metabolic Engineering Communications
journal homepage: www.elsevier.com/locate/mecProduction of tetra-methylpyrazine using engineered
Corynebacterium glutamicum
Thomas Eng a,b,1, Yusuke Sasaki a,b,c,d,1, Robin A. Herbert a,b, Andrew Lau a,b, Jessica Trinh a,b,
Yan Chen a,b, Mona Mirsiaghi b,e, Christopher J. Petzold a,b, Aindrila Mukhopadhyay a,b,f,*
a Joint BioEnergy Institute, Emeryville, CA, USA
b Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA
c Graduate School of Advanced Integrated Studies in Human Survivability, Kyoto University, Sakyo-ku, Kyoto, Japan
d Japan Society for the Promotion of Science, Sakyo-ku, Kyoto, Japan
e Advanced Biofuels Process Demonstration Unit, Lawrence Berkeley National Laboratory, Emeryville, CA, USA
f Environmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USAA R T I C L E I N F O
Keywords:
Corynebacterium glutamicum
Alkaloids
Terpene
2,3,5,6-Tetra-methylpyrazine
Isopentenol
Bioreactor* Corresponding author. Joint BioEnergy Institute
E-mail address: amukhopadhyay@lbl.gov (A. Mu
1 These authors contributed equally to this work
https://doi.org/10.1016/j.mec.2019.e00115
Received 2 August 2019; Received in revised form
2214-0301/© 2019 The Authors. Published by Else
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).A B S T R A C T
Corynebacterium glutamicum ATCC 13032 is an established and industrially-relevant microbial host that has been
utilized for the expression of many desirable bioproducts. Tetra-methylpyrazine (TMP) is a naturally occurring
alkylpyrazine with broad applications spanning fragrances to resins. We identiﬁed an engineered strain of
C. glutamicum which produces 5 g/L TMP and separately, a strain which can co-produce both TMP and the biofuel
compound isopentenol. Ionic liquids also stimulate TMP production in engineered strains. Using a fed batch-mode
feeding strategy, ionic liquid stimulated strains produced 2.2 g/L of tetra-methylpyrazine. We show that feedback
from a speciﬁc heterologous gene pathway on host physiology leads to acetoin accumulation and the production
of TMP.1. Introduction
Alkylpyrazines are naturally distributed, heterocyclic aromatic com-
pounds with a nutty or roasted ﬂavor proﬁle (Masuda andMihara, 1988).
Of the alkylpyrazine compounds, 2,3,5,6-tetra-methylpyrazine (also
known as TMP or ligustrazine) is a biologically active alkaloid commonly
found in the rhizobiome of Ligusticum wallichii (Ke-ji et al., 1983). It has
been used as a ﬂavoring agent (Zhu et al., 2010), studied as a potentially
pharmacologically active molecule (Chen et al., 2018; Ferreira and Kai-
ser, 2012; Kao et al., 2013), or applied onto surfaces as a coating (Lee,
2014; Ng et al., 2017). While TMP has been examined for potential use in
many ﬁelds, its widespread evaluation is hindered due to its limited
commercial availability. Chemical synthesis routes to TMP involve
multiple synthesis steps and are inefﬁcient (Dickschat Jeroen et al., 2010;
Deng et al., 2006). Commercially available TMP is often puriﬁed through
an ethanol-ethyl ether extraction from plants such as Ephedra sinica (Li
et al., 2001). More sustainable, biological routes towards TMP produc-
tion have focused on optimizing cultivation conditions of Bacillus subtilis,
which can naturally produce the TMP precursor, acetoin (Kosuge and, Emeryville, CA, USA.
khopadhyay).
.
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vier B.V. on behalf of InternationaKamiya, 1962; Xiao et al., 2014). TMP is inefﬁciently generated from
acetoin (26% yield) by heating the cell lysate to ~65 C for 2 h (Xiao
et al., 2014). Outside of B. subtilis, trace amounts of alkylpyrazines (such
as TMP) have been detected in the headspace of Corynebacterium gluta-
micum (Dickschat Jeroen et al., 2010), but evidence of higher titers of
TMP has only been reported from a single C. glutamicum isolate
(MB-1923) which is not publicly available and has no associated genomic
metadata (Demain et al., 1967). It has been postulated that TMP could be
produced from pyruvate via a four-step reaction (Fig. 1). The two units of
the proposed immediate precursor, acetoin (Rizzi, 1988), would spon-
taneously react with each other to form TMP under high nitrogen con-
centrations (Fig. 1).
In this communication, we examined engineered strains of
C. glutamicum for the production of TMP. Speciﬁc gene substitutions in a
heterologous gene pathway result in strains which produce high (>5 g/L)
titers of TMP or the co-production of TMP with an acetyl-CoA derived
compound, isopentenol (Sasaki et al., 2019). Other factors that enhance
the production of TMP in these engineered C. glutamicum strains are also
described.November 2019
l Metabolic Engineering Society. This is an open access article under the CC BY-
Abbreviations
TMP 2,3,5,6-tetra-methylpyrazine
GC/MS gas chromatography mass spectrometry
GC-FID gas chromatography ﬂame ionization detector
IL ionic liquid
[C2C1im][OAc] 1-ethyl-3-methyl imidazolium acetate
[Ch][OAc] cholinium acetate
[Ch][Lys] cholinium lysinate
[ETA][OAc] ethanolamine acetate
[DEOA][OAc] diethanolamine acetate
Table 1
Strains and plasmids used in this study.
Strain Description Selection Reference
JBEI-
7936
Corynebacterium glutamicum ATCC
13032/NHRI 1.1.2, biotin auxotroph
NxR Sasaki et al.
(2019)
JBEI-
19571
JBEI-7936 harboring p/JBEI-19559 KanR Sasaki et al.
(2019)
JBEI-
19652
JBEI-7936 harboring p/JBEI-19628 KanR This study
JBEI-
19658
JBEI-7936 harboring p/JBEI-19634 KanR This study
JBEI-
19566
JBEI-7936 ΔpoxB ΔldhA SucR,
KanS
Sasaki et al.
(2019)
E. coli
DH1
F λ– endA1 recA1 relA1 gyrA96 thi-1
glnV44 hsdR17(rK–mK–)
Meselson and
Yuan (1968)
E. coli
DH10β
F endA1 deoRþ recA1 galE15 galK16
nupG rpsL Δ(lac)X74 ϕ80lacZΔM15
araD139 Δ(ara,leu)7697 mcrA Δ(mrr-
hsdRMS-mcrBC) StrR λ–
Invitrogen
Plasmid Description Selection Reference
JBEI-
2600
pEC-XK99E, E. coli-C. glutamicum
shuttle expression vectors based on the
medium-copy number plasmid
including pGA1, KanR, oriV, Ptrc
KanR Kirchner and
Tauch (2003)
JBEI-
19559
pEC-XK99E-AK-IP-bypass KanR Sasaki et al.
(2019)
JBEI- pTE221 pEC-XK99E-AK-IP-bypass- KanR This study
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2.1. Chemicals and reagents
All chemicals and reagents were purchased from Sigma-Aldrich (St.
Louis, MO) or as otherwise indicated, and were of molecular biology
grade or higher. When cells were cultivated in a microtiter dish format,
plates were sealed with a gas-permeable ﬁlm (Sigma-Aldrich, St. Louis,
MO).19628 S. aureus mvaK1, mvaS (substitution)
JBEI-
19634
pTE222 pEC-XK99E-AK-IP-bypass-
C. kroppenstedtii mvaK1, mvaA
(substitution)
KanR This study2.2. Strain and plasmid construction
All strains and plasmids used in this study are listed in Table 1 and
their sequences are available at http://public-registry.jbei.org. Oligo-
nucleotide primers were synthesized by Integrated DNA Technologies,
Inc. (San Diego, CA). Q5 High-Fidelity DNA Polymerase (New England
Biolabs, Ipswich, MA) was used for polymerase chain reaction.
Isothermal DNA assembly (Gibson et al., 2009) was utilized to assemble
plasmids using 40 nucleotide overhangs (NEBuilder HiFi DNA Assembly
Master Mix, New England Biolabs, Ipswich, MA). Plasmids were con-
structed using chemically competent E. coli DH10β (New EnglandFig. 1. Diagram of proposed tetra-methylpyrazine (TMP) production pathway in C.
Model. Pyruvate is generated from glucose using the Embden-Meyerhof-Parnas (EM
synthase (ilvB, Cgl1271; ilvN, Cgl1272); AR, acetoin reductase (butA, Cgl2674). The u
This ﬁgure was adapted and expanded upon based on Xiao et al. (2014). Pathway f
2Biolabs). Where indicated, heterologous isopentenol production pathway
was modiﬁed to incorporate both hmgr and mk homologs from S. aureus
or C. kroppenstedtii, to replace the existing gene from S. cerevisiae. For
S. aureus, the mk homolog is encoded by mvaK1 (NCBI:
WP_000197034.1) and similarly, the hmgr homolog is encoded by mvaS
(NCBI: WP_045179588.1). For C. kroppenstedtii, the mk homolog is
encoded by mvaK1 (NCBI: ACR16826.1) and likewise, the hmgr homologglutamicum.
P) pathway and converted to TMP in four steps as indicated. ALS, acetolactate
pper-case letter S with arrows represents non-enzymatic spontaneous reactions.
or the production to isopentenol is described in Kang et al. (2016).
T. Eng et al. Metabolic Engineering Communications 10 (2020) e00115is encoded by mvaA (NCBI: WP_012730718.1). All sequences were
conﬁrmed by colony PCR and Sanger sequencing.
2.3. Growth media composition
Production was analyzed in several different common growthmedias.
Lysogeny-Broth (LB): 10 g/L tryptone, 5 g/L yeast extract, and 5 g/L
NaCl. Tryptone and yeast extract were purchased from BD Biosciences
(Franklin Lakes, NJ). NCM media (Ruan et al., 2015): 17.4 g/L K2HPO4,
11.6 g/L NaCl, 5 g/L D-glucose, 5 g/L tryptone, 1 g/L yeast extract, 0.3
g/L trisodium citrate, 0.05 g/L MgSO4⋅7H2O, and 91.1 g/L sorbitol, pH
7.2. CGXII minimal medium was prepared as previously described
(Keilhauer et al., 1993; Sasaki et al., 2019). D-glucose was used as a
carbon source at the 4% (w/v) concentration or as otherwise indicated.
2.4. Preparation of electrocompetent C. glutamicum cells
C. glutamicum was made electrocompetent as previously described
(Sasaki et al., 2019). In brief, cells were grown in NCM medium sup-
plemented with 3% (v/v) glycine and electroporated with a Micro Pulser
Electroporator (Bio-Rad Laboratories, Inc., Hercules, CA) at 10 μF, 600Ω,
and 1800 V. After electroporation cells were immediately mixed with
400 μL of BHIS broth and heat-shocked for 6 min at 46 C. After a
two-hour outgrowth at 30 C, cells were plated on the appropriate se-
lective agar plate.
2.5. Cultivation of C. glutamicum for isopentenol and TMP production
All cells taken from 80 C glycerol stocks were plated on LB agar
plates containing the appropriate antibiotic following standard labora-
tory procedures. Single colonies were inoculated and grown overnight in
5 mL LB media (with antibiotics as necessary) at 30 C on a rotary shaker
at 200 rpm. Kanamycin was added to the growth media at a ﬁnal con-
centration of 50 μg/mL. Unless otherwise noted, all seed cultures were
ﬁrst inoculated for growth in culture tubes. If cells were grown in a 24-
well deep well format, 2 mL of culture media was used per well. Deep
well plates were incubated Infors Multitron Incubator with a 3 mm
Orbital Shaking Platform shaken at 999 rpm (Bottmingen, Switzerland).
To measure production of TMP or isopentenol, the adapted cultures of
C. glutamicum were ﬁrst back-diluted to OD600 of 0.1 into CGXII minimal
medium including 4% (w/v) D-glucose at the concentrations described
above. Cells from a seed culture were sub-cultured twice to adapt cells to
grow in the media, as previously described (Sasaki et al., 2019). The
production pathway was then induced as before when cultures reached
an OD600 of ~0.8. Exogenous ionic liquids were added to the adapted
cultures at the same time of induction with IPTG.
2.6. Analytical methods for chemical identiﬁcation and quantiﬁcation
For metabolite quantiﬁcation, 300 μL of cell culture media was
combined with 300 μL of ethyl acetate containing n-butanol (10 mg/L) as
an internal standard and processed as described previously (Goh et al.,
2012; Kang et al., 2016; Sasaki et al., 2019). Brieﬂy, samples were shaken
at maximum speed for 15 min using an MT-400 microtube mixer (TOMY
Seiko, Tokyo, Japan) and then centrifuged at 14,000g for 3 min to
separate the organic phase from the aqueous phase. 60 μL of the organic
layer was transferred into a GC vial and 1 μL was analyzed by Agilent
GC/MS equipped with a DB-5 column (Agilent Technologies, Santa Clara,
CA, USA) or Thermo GC-FID equipped with a DB-WAX column (Agilent
Technologies, Santa Clara, CA, USA) for quantiﬁcation of TMP, acetoin,
diacetyl, and isopentenol (3-methyl-3-buten-1-ol). Analytical grade
standards were purchased from Sigma-Aldrich (St. Louis, MO) and used
to calculate analyte concentrations and conﬁrm identiﬁcation of peaks.
To compare the extraction efﬁciency of TMP into dichloromethane, the
same protocol as above was used where dichloromethane was used in
place of ethyl acetate as the extraction solvent. Reported TMP titers were3calculated using a linear curve of TMP peak areas normalized to
n-butanol generated from authentic standards resuspended directly into
ethyl acetate. Values were corrected for inefﬁcient extraction from CGXII
media into ethyl acetate by multiplying GC-FID values by 5.88 (refer to
Supplemental Fig. 1A).
To determine the spontaneous conversion rate of acetoin or diacetyl
to tetra-methylpyrazine, pure 100 mM of pure analytical grade standards
were added to CGXII media supplemented with 4% D-glucose. These
cultures were then incubated at 30 C as described in section 2.5 for 48 h,
after which samples were harvested for ethyl acetate extraction and
quantiﬁcation by GC-FID. Conversion of acetoin or diacetyl to TMP was
quantiﬁed using authentic standards, and samples were tested in
triplicate.
A commonly used extraction solvent, ethyl acetate, showed a 17%
extraction efﬁciency for TMP from CGXII culture media (Supplemental
Fig. 1A). While toxic and more challenging to handle, dichloromethane
showed a higher extraction efﬁciency for TMP at 50% from culture media
(Supplemental Fig. 1B).
2.7. Comparison of pathway protein abundance in E. coli and
C. glutamicum
E. coli (DH1) and C. glutamicum (ATCC 13032) strains harboring
plasmid pTE220 were cultivated as described in section 2.5. Cells were
grown in LB media supplemented with 56 mM glucose and 50 μg/mL
Kanamycin þ500 μM IPTG to ensure an equitable comparison between
these two hosts. Crude cell extracts containing were prepared exactly as
described in (Eng et al., 2018) and analyzed with an Agilent 6550 iFunnel
Q-TOF mass spectrometer (Agilent Technologies, Santa Clara, CA)
coupled to an Agilent 1290 UHPLC system, with a method as described
previously (Gonzalez Fernandez-Nino et al., 2015). To measure global
proteomic changes between pathway variants in C. glutamicum, we
analyzed the set of proteins absent in wild-type C. glutamicum but were
detected in the pathway variant samples by shotgun proteomics, ﬁltering
for proteins with at least two unique total peptides detected. Endogenous
proteins were functionally annotated using eggNOG-mapper (Huerta--
Cepas et al., 2017) to assign COG annotations (Galperin et al., 2014).
Hierarchical clustering using a one minus Pearson correlation was
calculated for both proteins and strains using the Morpheus software
package (https://software.broadinstitute.org/morpheus).
2.8. Fed-batch production of TMP in a 2 L bioreactor format
Fed-batch production was performed using a 2 L bioreactor equipped
with a Sartorius BIOSTAT B plus control unit for regulating dissolved
oxygen (DO), pH, and temperature. A seed train was used to generate the
starting inoculum for the bioreactor, which was electronically controlled
to a pH of 7.00.3 using 7.5 M ammonium hydroxide and 4 M sulfuric
acid. The temperature of the bioreactor was kept constant at 30 C
throughout the production time course. Diluted 10% (v/v) PEG-PPG-
PEG, Poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(-
ethylene glycol) (Sigma-Aldrich) was added as needed to control foam-
ing. During the initial growth phase, DOwas controlled at 30% saturation
by varying agitation speed from 400 to 1200 rpm, and then the air-ﬂow
rate was subsequently varied from 0.5 to 1.5 volume of air per volume of
medium per minute (vvm). Cultures were induced with 500 μM IPTG
after 3 h of the batch phase. After depletion of the starting D-glucose
(~10 g/L), feeding was initiated in low oxygen conditions by dropping
DO levels down to 0–5% of saturation by varying agitation speed from
400 to 750 rpm and gassing with 0.25 vvm, and the feeding rate was
controlled to keep the D-glucose concentration above 10 g/L. The feed
solution contained 500 g/L D-glucose, 5 g/L (NH4)2SO4, 1.5 g/L KH2PO4,
1.5 g/L K2HPO4, 5 g/L yeast extract, 0.5 mM IPTG, and kanamycin. At
speciﬁc timepoints, 5 mL samples were collected from the bioreactor by
syringe afﬁxed to the sampling tube and used for growth, GC-FID, and
HPLC analysis.
Fig. 2. mk and hmgR Variants from bacterial species bias production towards
tetra-methylpyrazine.
Top panel. Schematic of the heterologous isopentenol production pathway. The
two genes selected for optimization by substitution with homologs are indicated
with an asterisk (*). The proposed metabolic pathway for the conversion of
glucose to isopentenol has been previously described in Sasaki et al (2019).
Bottom panels. Analysis of the engineered isopentenol production pathway in
C. glutamicum using mk and hmgR homologs from S. aureus and C. kroppenstedtii
in a 24 well plate format. C. glutamicum ΔpoxB ΔldhA strain harboring the
original isopentenol production pathway (JBEI-19559) was compared with
variants where the S. cerevisiae MK and HMGR were replaced with mk and hmgR
from S. aureus (JBEI-19652) or C. kroppenstedtii (JBEI-19658). Samples were
cultivated in CGXII media 4% D-glucose in a 24 well plate format. TMP or iso-
pentenol titers were analyzed at the timepoints indicated and are an average of
three biological replicates. The error bars represent standard error.
T. Eng et al. Metabolic Engineering Communications 10 (2020) e001153. Results
3.1. Engineered strains harboring a heterologous gene pathway produce
tetra-methylpyrazine
We observed the formation of tetra-methylpyrazine (TMP) while
analyzing heterologous gene pathway variants expressed in engineered
C. glutamicum strains. In a previous study, we had engineered
C. glutamicum for the production of isopentenol using a heterologous,
mevalonate-based ﬁve gene pathway, referred to as the “original”
pathway (Sasaki et al., 2019). Pathway variants were constructed
because two of the genes (mk and hmgR derived from Saccharomyces
cerevisiae) were poorly expressed under standard laboratory growth
conditions (Supplemental Table 1). These variants were constructed by
substituting mk and hmgR gene homologs from either Staphylococcus
aureus or Corynebacterium kroppenstedtii into the heterologous gene
pathway and assayed for TMP production over a 48 h time course.
We report that these strains with two successfully expressed mk ho-
mologs (from S. aureus and C. kroppenstedtii) and hmgR from S. aureus
resulted in the production of TMP as detected by GC analysis (Fig. 2). In
the absence of a heterologous gene pathway, no new products were
detected. The C. glutamicum strain harboring the original pathway pro-
duced 300 mg/L isopentenol and did not produce detectable TMP. In
contrast to the original pathway, the S. aureus Mk, HmgR pathway variant
produced 2.2 g/L of TMP and ~200 mg/L of isopentenol. Furthermore,
the C. kroppenstedtii Mk, HmgR pathway variant produced 5 g/L of TMP
and did not produce isopentenol. These results indicate that the choice of
pathway variant expressed in C. glutamicum impacted the amount of TMP
produced.
Next, we examined if candidate TMP pathway proteins (Fig. 1) had
increased expression in these two new strains but did not detect signiﬁ-
cant differences in protein abundance for the three candidate pathway
genes, IlvB, IlvN, or ButA among the strain variants (Supplemental
Table 2). As there was no detectable change in protein abundance for the
pathway genes, we searched for proteome-wide changes to cellular
metabolism which could favor spontaneous conversion to TMP.
Four proteins involved in the tryptophan synthesis pathways (TrpE/
CgR_2916, TrpG/CgR_2917, TrpB/CgR_2920, TrpA/CgR_2921) were
newly detected in strains expressing the isopentenol pathway variants
from S. aureus or C. kroppenstedtii (Fig. 3 and Supplemental Table 2).
Additionally, two proteins involved in nitrogen metabolism (ArgJ/
CgR_1458, CgR_1470) were also identiﬁed as enriched in these strains.
There were four native proteins which were upregulated only in the
C. kroppenstedtii pathway variant strain: CgR_1697 (a putative cadherin-
like superfamily protein); CgR_2760 (a putative polyketide synthase);
CgR_0268 (a short-chain dehydrogenase); and CgR_2530 (uncharac-
terized protein, no predicted homologs). A systems level analysis (Gal-
perin et al., 2014) of the 83 upregulated proteins indicated that 53% of
these proteins were involved in cellular physiology, many related to
amino acid metabolism and transport (Fig. 3B). Of particular interest,
ortholog groups in protein translation related activities (category J) and
amino acid metabolism and transport (category E) were upregulated
(Fig. 3C). Complete data of all enriched proteins from these engineered
strains is plotted in Supplemental Fig. 2. As the expression of speciﬁc
heterologous gene pathways favored nitrogen-accumulating processes
that could enhance TMP production (Rizzi, 1988), it was reasonable that
the enrichment of new compounds could be favored in these variant
strain backgrounds.
3.2. Analysis of tetra-methylpyrazine biosynthesis and its downstream
extraction
To understand how TMP might be produced in these strains, we
examined the GC/MS trace ﬁles from these samples to determine if other
related pathway intermediates might also be detected. GC/MS analysis of
the additional analytes indicated the additional main peak to be tetra-4methylpyrazine, TMP (Fig. 4A peak no. 5 and Supplemental Fig. 3). We
also detected the accumulation of tri-methylpyrazine and 3,5-diethyl-2-
methyl-pyrazine but did not investigate either of these products any
further (Fig. 2, peak no. 4 and peak no. 6).
Consistent with the proposed pathway for pyrazine synthesis (Fig. 1),
we also detected S-Acetoin (3-Hydroxybutanone; Fig. 4A peak no. 1 and
Supplemental Fig. 3), the proposed precursor of tri/tetra-methylpyrazine
(Karp et al., 2011; Xiao et al., 2014). S-Acetoin was speciﬁcally identiﬁed
in samples with detectable TMP production levels and absent in samples
which did not produce TMP (Fig. 4B). The accumulation of acetoin in
these strains strengthens the evidence in support of the proposed bio-
logical route to produce TMP.
We next examined if TMP could form spontaneously from acetoin or
Fig. 3. Proteomic Analysis of Engineered C. glutamicum strains.
A. Hierarchical clustering of proteins enriched after heterologous gene pathway expression in engineered C. glutamicum strains. B. Gene functions of enriched proteins
as modeled with eggNOG-mapper to assign genes into categories of orthologous groups (COGs). WT C. glutamicum (JBEI-7936) was compared against strains harboring
the original isopentenol pathway (JBEI-19571) or the plasmid variants (JBEI-19652 and JBEI-19658). C. Distribution of enriched proteins into speciﬁc COGs. COGs
falling into related categories from the top panel are grouped together in brackets below. COG deﬁnitions: D, cell division and chromosome partitioning; M, cell wall
structure and biogenesis and outer membrane; O, molecular chaperones and related functions; T, signal transduction; Intracellular trafﬁcking, secretion; J, Translation,
ribosomal structure and biogenesis; K, transcription; L, replication, recombination, repair; C, energy production and conversion; E, amino acid transport and meta-
bolism; F, nucleotide transport and metabolism; G, carbohydrate transport and metabolism; H, coenzyme transport and metabolism; I, lipid transport and metabolism;
P, inorganic ion transport and metabolism; Q secondary metabolite transport and metabolism; S, unknown function.
T. Eng et al. Metabolic Engineering Communications 10 (2020) e00115diacetyl in the absence of a microbial host under biologically relevant
cultivation conditions. Previous TMP synthesis routes have a post-
cultivation step in which the culture broth is heated >60 C to favor
the synthesis of TMP (Rizzi, 1988; Xiao et al., 2104). However, it is un-
clear if a biologically relevant temperature with nitrogen concentrations
equal to that in the GCXII mediumwould be sufﬁcient for its spontaneous
conversion. To examine this, commercially purchased authentic stan-
dards for acetoin and diacetyl were spiked into CGXII media and tested
for the formation of TMP after the same cultivation time period of 48 h.
We did not detect spontaneous conversion of either acetoin or diacetyl to
TMP, suggesting production of the observed TMP requires the engineered
strain (Fig. 4C).3.3. Ionic liquids, a renewable pretreatment reagent, enhances production
of tetra-methylpyrazine
Most sustainable production requires the use of renewable carbon
sources such as plant-derived biomass and pose trade-offs due to the
incompatibilities between processes (Baral et al., 2019b; Eng et al., 2018;
Ouellet et al., 2011; Sasaki et al., 2019; Wang et al., 2018). We evaluated
the behavior of C. glutamicum strains when cultivated with reagents used
in the pretreatment of sustainable carbon streams. Speciﬁcally, we asked
if trace levels of ionic liquids, a promising reagent for plant biomass
deconstruction (George et al., 2015; Li et al., 2010), changed the amount
of TMP produced in strains expressing the original IP pathway.
We characterized the effect of three different classes of ionic liquids5on the behavior of engineered C. glutamicum strains for the production of
TMP. The ionic liquids chosen were acetate salts with 1-ethyl-3-methyl
imidazolium ([C2C1im]þ); cholinium ([Ch]þ); ethanolamine [ETA];
and diethanolamine [DEOA], [ETA] and [DEOA] cations. [C2C1im] and
[Ch] are two biogenic ILs whereas [ETA] and [DEOA] are two repre-
sentative protic ILs. We detected TMP at the 48 h time point under these
ILs-stressed conditions (Fig. 5). In the presence of exogenous 150 mM
[C2C1im][OAc], we detected 63 mg/L TMP. Interestingly, in contrast to
bioproduction in other microbial hosts (Eng et al., 2018; Ouellet et al.,
2011), we did not observe inhibition of production in the presence of ILs.
Rather, when treated with 150 mM [Ch][OAc], we detected higher levels
of TMP production, with titers reaching 1021 mg/L. Of the protic ILs,
treatment with 150 mM [ETA][OAc] produced a similar titer to [Ch]
[OAc], with measured titers around 1050 mg/L. 150 mM [DEOA][OAc]
treatment resulted in an accumulation of TMP to 585 mg/L. When
expressed in C. glutamicum, the original IP pathway does not produce
TMP under standard cultivation conditions, but treatment with speciﬁc
ILs result in TMP production from undetectable to over 1 g/L.
Ionic liquids alone were not sufﬁcient to induce TMP production in
wild-type C. glutamicum (Supplemental Fig. 1C). The amount of TMP
produced in response to the IL was more variable when treating cells with
75 mM ILs, but TMP still accumulated in the same set of ILs. These strains
also co-produced TMP and ~350 mg/L isopentenol using the unmodiﬁed
isopentenol production pathway (Supplemental Fig. 4). These results
provide a new perspective on using ILs as pretreatment reagents. Rather
than framing ILs as pretreatment contaminants that must be removed,
Fig. 4. GC/MS analysis of tetra-methylpyrazine and S-acetoin. A. Identiﬁ-
cation of tetra-methylpyrazine and other peaks by GC/MS analysis. The geno-
types of the strains used were the same as described in Fig. 2. Peak identiﬁcation.
1. Acetoin (3-hydroxy-2-butanone). 2. Isopentenol (3-methyl-3-buten-1-ol). 3. 4-
penten-1-ylacetate. 4. 2,3,5-tri-methyl-pyrazine. 5. 2,3,5,6-tetra-methyl-pyra-
zine. 6. 3,5-diethyl-2-methyl-pyrazine. B. Comparison of acetoin peak height
across different engineered strains by GC/MS analysis. C. Detection of sponta-
neous TMP formation in CGXII media from precursors, acetoin or diacetyl, after
48 h post incubation. 100 mM of either acetoin or diacetyl was added to CGXII
media. As a reference, TMP produced from the C. kroppenstedtii variant in JBEI-
19658 is replotted from Fig. 2 on the same graph.
Fig. 5. Speciﬁc forms of ionic liquids induce tetra-methylpyrazine production in
C. glutamicum.
The production proﬁles of the C. glutamicum (JBEI-19571) against three types
(imidazolium, cholinium, and protic form) of ionic liquids were examined in
CGXII media with 4% D-glucose in a 24 well plate format. ([C2C1im]þ); choli-
nium ([Ch]þ); ethanolamine acetate [ETA][OAc]; and diethanolamine acetate
[DEOA][OAc] A. Produced titers of tetra-methylpyrazine are shown at 48 h post
induction under 75 mM (A) or 150 mM (B) [C2C1im][OAc], [Ch][OAc], [ETA]
[OAc], and [DEOA][OAc]. The control experiment was performed without IL
supplementation (No ILs). Data shown are an average of biological triplicates,
and the error bars represent standard error.
T. Eng et al. Metabolic Engineering Communications 10 (2020) e00115trace ionic liquids remaining from biomass pretreatment regimes could
be beneﬁcial as inducers allowing the coproduction of TMP and
isopentenol.3.4. Production of TMP in fed batch mode cultures
Having observed the accumulation of TMP in our engineered strains,
we wanted to next determine if TMP production could be produced under
more industrially relevant cultivation conditions. We thus changed our
cultivation format from a 24 well deep well microtiter dish to a 2L
bioreactor format in fed batch mode. To retain ﬂexibility in the choice of
the ﬁnal product, we added 50 mM of the IL [Ch][Lys] to stimulate TMP
production in the engineered C. glutamicum strain using the original
pathway. In fed-batch mode, the rate of TMP production was slower than
what was observed in batch mode, as we only detected 700 mg/L of TMP
after 48 h of cultivation (Fig. 6, compare to time course in Fig. 2). It is
possible that TMP is only produced after nutrient exhaustion in station-
ary phase, as we only detected TMP production 6 h after the ﬁnal addi-
tion of the feed solution. The TMP titer after 65 h cultivation reached 2 g/
L (Fig. 6), which was higher than the ﬁnal titer in the smaller lab-scale
format using IL-stimulated production (compare with Fig. 5). Iso-
pentenol production under these cultivation conditions was near the
detection limit (5 mg/L) potentially due to the increased aeration from6the impeller driven mixing inherent to cell growth conditions in the
bioreactor (Fig. 6). We attempted to phase separate isopentenol with a
dodecane overlay (Peralta-Yahya et al., 2011), but dodecane inhibited
growth of C. glutamicum under these conditions. These results indicate
the scalability of TMP production under industrially relevant formats, but
further work would be required to co-produce isopentenol.
4. Discussion
This report illustrates two parameters by which C. glutamicum can be
modiﬁed to produce tetra-methylpyrazine, TMP. Our highest ﬁnal titers
from batch and fed-batch production modes compare favorably with
published titers from Bacillus subtilis (Xiao et al., 2014; Yin et al., 2018)
and do not require a post-cultivation denaturing step to produce TMP.
Unlike E. coli, C. glutamicum responds to the burden of expressing a
heterologous IP pathway by accumulating TMP. A previous report had
indicated that redirecting central metabolism in C. glutamicum away from
acetate led to the accumulation of high intracellular levels of acetoin
(Mao et al., 2017), but did not report TMP in their strains. This result
from Mao et al. is consistent with our hypothesis, in which the burden of
a speciﬁc heterologous gene pathway can instead favor high level TMP
accumulation. Moreover, the kinetics of TMP formation is dependent on
the speciﬁc pathway variant analyzed. There are likely some interactions
between the heterologous gene pathway and native metabolism at the
metabolite level. Efﬁcient and universal metabolite quenching for
metabolic ﬂux analysis could be utilized to examine this possibility
(Wellerdiek et al., 2009; Zhang et al., 2018).
Certain ionic liquids are known to impact cellular morphology and
physiology (Mehmood et al., 2015). Their impact on engineered strains
can also be pathway-speciﬁc; in E. coli, the addition of an isopentenol
production pathway to an IL-tolerant strain can result in acetate accu-
mulation rather than isopentenol (Eng et al., 2018). In contrast, limonene
can be produced from the same IL-tolerant strain without detectable
acetate accumulation (Eng et al., 2018). While additional studies are
required to understand the beneﬁcial impact of ionic liquids on the
production of TMP in engineered C. glutamicum strains, this study pro-
vides an alternate paradigm of ILs as a useful tool for improving
Fig. 6. Fed-batch mode production of TMP in engineered C. glutamicum.
C. glutamicum (JBEI-19571) was initially cultivated in batch mode using CGXII
minimal media including 8% starting D-glucose and 50 mM [Ch][Lys] in a 2L
Sartorius Bioreactor. Subsequently, fed-batch mode was initiated when the
initial D-glucose concentration decreased below 1%. A pulse mode feeding
strategy was utilized to raise the D-glucose concentration above 1%. Final
products and organic acid concentrations were quantiﬁed and are indicated as
labeled in the legend above.
T. Eng et al. Metabolic Engineering Communications 10 (2020) e00115production instead of merely being an unwanted contaminant. The added
burden of ionic liquids could be a new metric for assessing how a het-
erologous gene pathway can impinge upon native metabolism, especially
when evaluating hosts originating from different environmental niches
and primary carbon sources (Wehrs et al., 2019).
The production of TMP is correlated with the accumulation of ace-
toin, providing additional evidence to strengthen its proposed biosyn-
thetic pathway (Fig. 1). We do not detect abiotic accumulation of TMP
from either acetoin or di-acetyl when added directly into culture media
(Fig. 4C). Rather our results suggest that TMP production is strain
dependent and likely involve the accumulation of acetoin. These obser-
vations highlight the importance of considering both the speciﬁc heter-
ologous gene pathway as well as potential feedback on the chosen
microbial host. With high titers of TMP, these C. glutamicum strains will
facilitate rapid evaluation of TMP derivatives using candidate enzyme
libraries to be expressed in a gram-positive microbial host (Hu et al.,
2018; Stankeviciut _e et al., 2016; Zhang et al., 2016). Being able to pro-
duce>1 g/L quantities of many TMP derivatives will unlock the potential
of this emerging molecule for a broader spectrum of applications.
While we report the exclusive production of TMP, examples of the co-
production of two different ﬁnal products from the same microbial host
can also be of value (Liang and Qi, 2014). As these two compounds have
distinct applications, such an industrial process would likely require
reﬁnement of existing puriﬁcation techniques for efﬁcient separation.
Isopentenol easily partitions into organic solvents such as ethyl acetate,
and TMP can be precipitated from the aqueous phase after cooling to ~4
C (Xiao et al., 2006). This report is also the ﬁrst instance in which either
TMP or isopentenol has been the ﬁnal product for a co-production study.
The use of TMP as a possible co-produced compound with isopentenol
will allow more nuance and control in the technoeconomic analysis of
scaling up either product (Baral et al., 2019a, 2019b).
5. Conclusions
In summary, this report describes the successful use of the gram-
positive industrial microorganism, C. glutamicum, for the high titer7(>5 g/L) production of TMP. These strains can also be used to co-produce
TMP as well as the biofuel candidate, isopentenol. Production of TMP
was scaled-up to industrially relevant conditions in a 2L fed-batch
bioreactor, where we observed 2 g/L TMP when cells were treated
with exogenous ionic liquid.
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